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a b s t r a c t
The P2 protein in Plasmodium falciparum has a high tendency to oligomerize, which seems to drive many
of its non-ribosomal functions. During nuclear division of the parasite inside RBC, P2 translocates to the
RBC surface as a tetramer. From a systematic study using variety of biophysical techniques, NMR spectral
characteristics and relaxation dispersion measurements under different conditions of pH and/or urea
concentrations, we deduce that (i) PfP2, an almost entirely helical protein, forms a molten globule
monomer at low pH, (ii) at physiological pH, and at micro-molar concentrations, PfP2 is a stable tetramer
wherein two dimmers associate sideways with close packing of helices at the interface, and (iii) the
molten globule characteristic of the monomer is preserved in the tetramer. This dynamism in the
structure of PfP2 may have functional implications since it is known that different kinds of oligomers are
transiently formed in the parasite.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Plasmodium falciparum P2 is a ribosomal stalk protein. In higher
eukaryotes P1 and P2 proteins interact with P0 forming a penta-
meric P0-(P1/P2)2 complex and are collectively known as P-
proteins [1,2]. Interestingly, Plasmodium falciparum P2 (PfP2) is
known to be involved in non-ribosomal functions as well and this
seems to be associated with its tendency to homo-oligomerize [3].
Malaria parasites develop within the erythrocytes where P2
protein within the parasite body remains largely monomeric until
the onset of cell division [3]. P2 protein alone translocates to the
infected RBC surface for 6–8 h prior to nuclear division and this
translocation is concomitant with extensive oligomerization in the
parasite body. The amount of P2 protein is also found to oscillate
with the highest amount of P2 protein being formed at 24 h PMI.
Within the erythrocytic development cycle of 48 h in synchro-
nized Plasmodium falciparum cells, the high concentration of PfP2
protein and its extensive oligomerization mainly at 24 h PMI
indicates a deﬁnitive role for PfP2 oligomerization, the precise
nature of which is yet to be elucidated. At that point a large
number of SDS-resistant higher oligomers of P2 protein are
detected, but on the infected-erythrocyte surface, only the SDS-
resistant homo-tetrameric form of P2 is found [3].
Recent observations have shown that the recombinant human
P2 protein is stable as a dimer in solution and this has 69%
sequence similarity with PfP2 [4]. In the presence of P1 (25%
sequence similarity with P2) of the same species, it forms a stable
heterodimer [5]. However, interestingly the core structure in both
these homo and hetero-dimers is identical [4,5]. A very recent
report on the Plasmodium P-protein assembly demonstrated a lack
of stable hetero-dimeric complex of P1/P2 proteins, indicating a
distinct behavior of these Plasmodium proteins [6]. In this study it
was observed that PfP1 and PfP2 proteins do not form hetero-
dimers, and that in the presence of all three P-proteins, the
assembly of pentameric P0-(P1/P2)2 occurred directly, bypassing
the stable hetero-dimeric complex.
In this paper we have tried to investigate by NMR and other
biophysical methods the structural and dynamic characteristics of
PfP2 at residue level detail. This has been challenging since the
NMR spectra of PfP2 do not show more than half the number of
expected peaks, which is in contrast to the situation in human P2
protein. Nevertheless, we have been able to show that the stable
unit of PfP2 in solution in-vitro is a tetramer at micro-molar
concentrations. Using a strategy of partially unfolding the tetramer
for observing NMR signals from all the residues, gathering insights
into structural and motional transitions, and based on the pub-
lished dimeric structure of human P2 protein, we propose a model
for the structure of the PfP2-tetramer.
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2. Materials and methods
2.1. Protein expression and puriﬁcation
Protein expression and puriﬁcation has been described else-
where [7,8]. Isotopically enriched (15N or 15N and 13C) PfP2 was
prepared using M9 media containing 15NH4Cl and 13C glucose as
the sole sources of nitrogen and carbon, respectively. The puriﬁed
protein was concentrated to 1 mM concentration. Sample was
then exchanged to 6 M, 5 M and 4 M urea solutions prepared in
100 mM MES buffer containing 150 mM NaCl and 1 mM DTT
adjusted to pH 5.6. Urea concentration was calculated using
refractive index measurements. The NMR samples (containing
10% D2O (v/v)) were allowed to attain equilibrium before starting
the experiments.
2.2. NMR spectroscopy
Relaxation dispersion NMR measurements were performed at
251 C on Bruker 500 MHz and 800 MHz equipped with a room
temperature probe and cryoprobe with triple axis gradients. Other
relaxation experiments were recorded on Bruker 800 MHz
equipped with a cryo probe with triple axis gradients. All pulse
schemes were gradients and sensitivity enhanced and employed
water ﬂip back for optimal water suppression [9–11]. Milliseconds
(ms) conformational dynamics can be quantiﬁed using CPMG
relaxation dispersion NMR techniques [12–14]. In all these experi-
ments constant time relaxation compensated pulse sequence
developed by Kay and coworkers were used [15]. These are
essentially Car–Purcell–Meiboom–Gill (CPMG) 15N T2 measure-
ments recorded by varying the number of π pulses in a constant
time (Trelax) spin echo sequence. A 1H continuous spin-lock ﬁeld is
applied during the 15N CPMG π pulse train. A constant duty cycle
was maintained by incorporating additional RF pulses following
the free induction decay for compensating sample heating effects
[16]. The CPMG frequency (νCPMG) is determined by the number of
15N CPMG π-pulses applied during the Trelax period, according to
the relation given by [15]
vcpmg ¼
1
2ð2τCPþt180;NÞ
ð1Þ
where 2τCP is the spacing between successive 15N CPMG π pulses.
In our experiment the pulse width was t180,N¼90 ms. We have
varied νCPMG between 33.33 and 1000 Hz. Spin lock ﬁelds of the
proton used were between 8.5 and 11 kHz range, and the RF
amplitude is ﬁne-tuned for each νcpmg value in order to ensure that
the integral number of 1H π pulses can be accommodated within
Trelax. Equilibration delay of τeq¼5 ms was used before and after
the water alignment as was reported [15]. For, νCPMG¼33.33–
100 Hz and νCPMG¼800–1000 Hz the data was collected in tripli-
cate for purposes of error calculation. One experiment with no
CPMG relaxation delay was also recorded as a control (i.e.
Trelax¼0). For each backbone amide 15N residue, the effective
transverse relaxation rate, R2,eff, as a function of νcpmg was
calculated as [25, 26]
R2;eff vcpmg
 ¼ 1
Trelax
ln
ICPMG
I0
 
ð2Þ;
where Trelax¼30 ms relaxation delay and I(νcpmg) is the peak
intensity for the particular CPMG frequency and peak intensity
in the control spectrum recorded (Trelax¼0) is I0.
NMR data were processed in NMRPIPE and motional para-
meters were extracted. For the CPMG relaxation dispersion
experiments, uncertainties in the measured R2,eff were calculated
using
ΔR2;eff vcpmg
 ¼ 1
Trelax
ln
ΔI
IðvcpmgÞ
 
ð3Þ;
where ΔI is the average standard deviation obtained from two sets
of triplicate points mentioned before. For each residue CPMG
relaxation dispersion trajectories at 500 and 800 MHz λH frequency
were used to calculate corresponding exchange contributions to 15N
R2 according to Rex¼R2,eff(νcpmg¼0)R2,eff(νcpmg¼1000). This ana-
lysis has identiﬁed regions undergoing signiﬁcant chemical
exchange.
2.3. Gel ﬁltration of recombinant PfP2
AKTA FPLC from GE Healthcare was used for gel ﬁltration which
was coupled to UV spectrometer. The gel ﬁltration proﬁle of
recombinant PfP2 at pH 7.4 and pH 2.0 and urea denatured protein
was determined using Superdex-75 column, using appropriate
concentrations; 90 fractions were collected. The parameters used
for gel ﬁltration were: pressure 0.5 MPa, column bed volume
120 ml, ﬂow rate: 0.5 ml/min. All runs were done under reduced
condition (5 mM DTT) at room temperature. The proﬁles were
then compared with proﬁles of marker-proteins run on the same
column.
2.4. Mass spectrometry of PfP2 using MALDI-TOF
The tetramer and the monomer fraction from the gel ﬁltration
proﬁle was collected and subjected to mass spectrometry using
MALDI from Bruker Corporation (model number 201344). The
protein was dissolved in phosphate buffer, pH 7.4 and glycine
buffer at pH 2.0, and reconstituted using 50% acetonitile and 0.1%
TFA (500 ml of 100% acetonitrile 499 ml of distilled waterþ1 ml of
TFA). The reconstituted protein was loaded on a MALDI plate using
saturated solution of α-cyanohydroxylcinnamic acid (Bruker
201344) (20 mg/ml) in 50% acetonitrile and 0.1% TFA.
2.5. Circular dichroism (CD) spectroscopy
The spectra in the far-UV CD (190–260 nm) and the near-UV CD
(260–360 nm) regions were obtained on a JASCO-810 spectro-
polarimeter for observing the alterations in the secondary and
tertiary structure of the protein. The concentrations of protein and
path lengths used were 50 μM and 0.2 cm, respectively for the far-
UV CD experiments, and 50 μM and 1 cm, respectively for near-UV
CD experiments. The spectropolarimeter was thoroughly purged
with nitrogen gas before starting the experiments. Each spectrum
was baseline corrected and was taken as an average of three
accumulations at a scan rate of 50 nm min1, and a response time
of 1 s. The molar ellipticity θ½  was calculated from the observed
ellipticity θ as
θ½  ¼ 100U θ
cU l
 
ð4Þ
where c is the concentration of the protein in M (mol dm3) and l
is the path length of the cell in centimeters.
2.6. Fluorescence spectroscopy
The intrinsic ﬂuorescence properties of the proteins were
studied on a Cary Eclipse spectroﬂuorimeter with a 3 mL quartz
cell of 1 cm path length. The concentration of PfP2-tetramer and
PfP2-monomer was kept at 0.063 mM and 0.030 mM in the steady
state ﬂuorescence experiments. The excitation and emission slit
widths were ﬁxed at 5 nm. For ANS binding experiments, the ANS
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concentration was kept at 0.047 mM which was determined using
an extinction coefﬁcient value of 5000 M1 cm1 [17]. The excita-
tion wavelength was set at 365 nm to selectively excite the ANS
molecules, and the emission spectra were monitored in the
wavelength range of 400–600 nm. The emission spectra of the
protein-ANS solutions were subtracted from the buffer-ANS
blanks, and an average of three accumulated scans was recorded
as the ﬁnal graph.
2.7. Isothermal titration calorimetry
The values of thermodynamic parameters accompanying the
binding of ANS with PfP2-tetramer were determined using an
isothermal titration calorimeter (VP-ITC, Microcal, Northampton,
MA, USA) at T¼25 1C. The ANS solution, taken in the syringe, was
titrated into the sample cell in aliquots using a 250 μl rotating
stirrer-syringe, and the reference cell contained the buffer. Each
experiment consisted of 50 consecutive injections of 5 μl of the
ANS solution into the sample cell containing PfP2-tetramer. The
duration of each injection was kept at 10 s with a 4 min interval
between the consecutive injections. Origin 7.0 software, provided
by Microcal was used to analyse the titration heat proﬁles. The
total heat content Q of the solution contained in the active cell
volume Vo (determined relative to zero for the unliganded species)
at fractional saturation Θ after the ith injection is determined from
[18],
Q ¼ nΘMtΔHUVo ð5Þ
where Mt is the total concentration of the protein, n is the number
of binding sites in the macromolecule and ΔH is the molar heat of
drug binding. The heat released ΔQ(i) from the ith injection for an
injection volume dVi is then given [18] by the following equation:
ΔQ ðiÞ ¼ Q ðiÞþdVi
Vo
Q ðiÞþQ ði1Þ
2
 
Q ði1Þ ð6Þ
The thermodynamic parameters thus obtained associated with the
binding process are binding constant (K), enthalpy of binding (ΔH),
entropy of binding (ΔS), and stoichiometry of binding (n), which
were determined by the best ﬁt of the chosen model to the
experimental data points.
2.8. Modelling
A model for the PfP2-tetramer was generated starting from the
published dimeric structure of human P2 and the experimental
constraints derived in the present study. First, the sequence of
human P2 was mutated to match that of PfP2 sequence using
swissPDB viewer [19]. Then the resulting dimer was energy
minimized. Next, by including constraints of contacts between
two dimers, derived from Rex data we docked two units of dimers
by using ZDOCK [20] to arrive at a model structure for PfP2
tetramer.
3. Results and discussion
3.1. PfP2-forms a tetramer at physiological pH at micro-molar
concentrations
We have recorded gel ﬁltration proﬁle of recombinant PfP2 at
64 and 350 mM concentrations at pH, 7.4. In both cases the proﬁles
were similar and Fig. 1A shows the chromatograms obtained with
protein concentration of 350 mM. For comparison the proﬁle
obtained for BSA marker (66 kDa) is also shown as seen in
Fig. 1B. From this it can be seen that PfP2 forms a stable tetramer
in solution. This fraction pool of PfP2 was subjected to MALDI for
an accurate estimate of molecular size, and a mass of 70.1 kDa was
observed (Fig. 1C). This was for triply labelled (2H/15N/13C) PfP2-
tetramer.
3.2. PfP2 forms a molten globule monomer at pH 2
Fig. 2 shows the FPLC chromatogram of PfP2 at pH 2. It can be
clearly seen that the molecule is a monomer with a molecular
weight of 15.5 kDa.
The CD spectra of the protein under the same conditions,
shown in Fig. 3A, indicate that the protein has prominent helical
structure as indicated by bands at 208 and 222 nm and very less
tertiary structure as indicated by low ellipticity in the region 260–
340 nm. Further, we observe that ANS, a dye which is known to
bind strongly to partially folded states or molten globule states of
proteins [17,21,22], binds to PfP2 at pH 2 as shown in Fig. 3B; the
dye exhibits very little ﬂuorescence in free solution or when the
protein is fully denatured in 8 M urea, but shows very high
ﬂuorescence when added to solution containing PfP2 monomer
alone at pH 2. Moreover, the 1H–15N HSQC spectrum of the protein
in Fig. 3C shows only 40 peaks as against the expected 138 peaks
for the full protein. This can be attributed to ms-ms time scale
Fig. 1. Gel ﬁltration proﬁles: (A) recombinant PfP2 (loading:1 ml of 4 mg/ml);
(B) BSA protein marker (loading:1 ml of 1 mg/ml) run on the same column;
(C) MALDI spectrum of deuterated 2H/13C/15N PfP2 tetramer.
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dynamics in major portion of the protein which results in
disappearance of the peaks belonging to those residues. All these
observations are indicative of a molten globule like structure for
the PfP2 monomer at pH 2.
3.3. Structural features of PfP2-tetramer
3.3.1. Secondary and tertiary structural characteristics
Recently, we have described structural characterization of PfP2
at a rather high concentration (mM) where it was seen to form a
mixture of oligomers, the predominant species being an octamer
[7]. This involved CD and NMR studies. Interestingly, the present
observations on the pure tetramer coincide almost entirely with
those and thus the conclusions regarding some general character-
istics can be extrapolated here as well. For purpose of ready
comparison, we show here the circular dichroism (CD) (Fig. 4A)
and HSQC (Fig. 4C) spectra of the tetramer. One can see that the
far-UV CD spectra (Fig. 4A) at pH 7.4 showed two negative bands at
210 nm and 222 nm which are indicative of helical structures. The
near-UV CD spectra of PfP2 (Fig. 4B) at pH 7.4 showed weak
ellipticity in the wavelength range of 260–280 nm, indicating that
the tetramer has a loose tertiary structure.
Likewise, the HSQC spectrum shown here overlays exactly with
that reported previously [7] and thus the assignments of the
individual peaks can be readily transferred. The HSQC spectrum
shows only 43 peaks and these belong to the C-terminal residues
of the polypeptide chain. Secondary shift calculations reported
earlier [7,8] can also be transferred to the present case and we
conclude that the C-terminal segment is devoid of any secondary
structural preferences.
3.3.2. Hydrophobic surfaces in PfP2-tetramer
The presence of hydrophobic surfaces/pockets in proteins is
often probed by binding of ANS, which being hydrophobic in
nature can selectively access such regions in the protein, and
optical properties are very sensitive to the polarity of its micro-
environment. Enhanced emission intensity upon binding with
nonpolar surfaces has been observed [22,23], when excited at
365 nm. In the presence of a partially folded protein with exposed
hydrophobic surfaces, the ﬂuorescence emission intensity is
enhanced and the emission maximum is blue shifted compared
to that of free ANS [21]. Fig. 5A shows the ﬂuorescence emission
spectra of 0.047 mM ANS, in the presence of native PfP2-tetramer
(concentration: 0.063 mM) and upon urea denaturation at pH 7.4.
We observed that ANS binding to the protein is maximum in its
native state (absence of urea) and decreases gradually when the
urea concentration is increased from 1 M to 8 M.
Isothermal titration calorimetry (ITC) provides valuable infor-
mation on binding of ligands to proteins. A representative iso-
thermal titration calorimetric proﬁle for the binding of 15 mM ANS
with 0.075 mM protein at pH 7.4 and 25 1C is shown in Fig. 5B; this
is a resultant of 50 injections to ensure full saturation of the
binding sites. Each peak in the binding isotherm represents a
single injection of ANS into the protein solution. The lower panel
of Fig. 5B shows the plot of heat change per injection as a function
of the molar ratio of ANS to PfP2-tetramer.
From the above data, it appears that ANS is able to ﬁnd more
than one binding sites on PfP2-tetramer with varying degrees of
exothermicity. A sequential two-binding sites model ﬁtted the
data with the values of binding constants of (9.8470.2)103 and
(17272.7) M1 and binding enthalpies of (8.570.2) kJ mol1 and
(0.2870.04) kJ mol1, respectively. The major binding event
(K1) is accompanied by an endothermic enthalpy of binding with a
gain in entropy; out of the two binding events only one corre-
sponding to K2 shows exothermic binding effects. ANS is known to
bind the partially folded states of proteins both via hydrophobic
and ionic interaction due to its molecular properties. The ionic
interactions contribute to the exothermic heating effects whereas
hydrophobic interactions impart endothermic contribution.
The thermodynamic parameters obtained from the ITC mea-
surements permit insights into the factors that contribute to the
complexation of ANS to the loosely compacted state of PfP2-
tetramer. The major binding event which is accompanied by
endothermic enthalpy and positive entropy is suggestive of hydro-
phobic interactions. The minor event which is exothermic in
nature can be attributed to weak ionic interactions.
To gain residue speciﬁc information with regard to the hydro-
phobic pocket, we recorded 2D 1H–15N HSQC spectra on native
deuterated PfP2-tetramer with and without ANS (Fig. 5C). We do
not observe chemical shift changes for most of the residues in the
C terminal on addition of ANS, indicating that the C-terminal
domain does not interact with ANS. In other words, the hydro-
phobic pocket is constructed by the N-terminal portion of the
protein.
3.3.3. Molten globule structure is preserved in the tetramer
The circular dichroism spectrum of the tetramer in the far UV
region showed a very weak band at 280 nm and overall the signal
is very weak. This gave an indication that the tertiary structure in
the tetramer is perhaps not very rigid. Similar conclusion is also
evident from the NMR data as follows. The molecular weight of the
tetramer is 62 kDa. This is not such a large molecular mass that the
NMR signals become non observable due to slow tumbling
Fig. 2. Gel ﬁltration proﬁles: (A) recombinant PfP2 at pH 2.0 (loading: 1 ml of 2 mg/
ml); (B) Lysozyme protein marker (loading:1 ml of 1 mg/ml) run on the same
column; and (C) MALDI spectrum of unlabelled PfP2 monomer.
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Fig. 3. PfP2-monomer spectra at pH 2.0: (A) far-UV CD spectrum of 50103 mM PfP2 (top panel), and near-UV CD spectrum of 50103 mM PfP2 (bottom panel);
(B) Fluorescence emission spectra of 0.047 mM ANS, with 0.030 mM PfP2-monomer (red), with buffer alone (black), and with denatured PfP2 in 8 M urea (green); (C) 2D
1H–15N HSQC spectrum of PfP2-monomer at 251 C at pH 2.0.
Fig. 4. PfP2 tetramer spectra at pH 7.4: (A) far-UV CD spectrum of 50103 mM PfP2 and (B) near-UV CD spectrum of 50103 mM PfP2; (C) 2D 1H–15N HSQC spectrum of
PfP2-tetramer at 251 C at pH 7.4.
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motions. In fact, the C-terminal segments from each of the chains
in the tetramer do produce signals, and that of course indicates
high ﬂexibility of this domain. Deuteration of the chain did not
produce any more peaks in the spectrum. This indicates that
vanishing of the signals, for the core of the tetramer is due to
other reasons and most naturally, that must be slow ﬂuctuations in
the packing of the helices in the core.
A further insight comes from comparison of the HSQC spec-
trum of the tetramer with that of the monomer observed at pH 2.
It is interesting to note that in both cases the number of peaks
observed in the spectra are nearly the same. Some peaks appear to
be shifted, but this must be attributed to protonation of some side
chains (eg, Glu and Asp) at low pH. Thus, combining both CD and
NMR observations, we can safely conclude that the molten globule
nature of the monomer is preserved in the tetramer.
3.4. Elucidation of step-wise assembly of tetramer
To gain insights into the assembly of the tetramer we adopted
the strategy of systematic dissociation of the tetramer using urea
as the dissociating agent and monitor the changes that occur in
the spectra. Previous studies on the octamer had indicated that the
denaturation transition by urea occurs in the concentration range,
3–7 M urea at pH 5.6 [8]. Therefore, we decided to focus attention
to the range 4–6 M urea and monitored the step-wise dissociation
using FPLC, and this was done at two pH values, 5.6 and 7.4. It
turned out that the results are identical in the two cases and here
we show the results at pH 5.6. Fig. 6 shows the FPLC chromato-
grams at the three concentrations.
The FPLC proﬁles indicate that at 4 M urea there is a pure
tetramer, at 5 M urea a small population of dimer appears, and at
Fig. 5. ANS binding to PfP2 tetramer. (A) Fluorescence emission spectra of 0.047 mM ANS, with 0.063 mM PfP2-tetramer in the presence of varying urea concentrations from
0 M to 8 M at pH 7.4. (B) Raw data for the titration of 15 mM ANS in 0.075 mM PfP2 at pH 7.4 and 25 1C showing the calorimetric response as successive injections of ligand
are added to the sample cell (upper panel). The lower panel shows the integrated heat proﬁle of calorimetric titration. (C) 2D 1H–15N HSQC spectrum at 251 C of:
(i) deuterated PfP2-tetramer at pH 7.4, (ii) Overlay of spectra of PfP2 with and without ANS. Protein: ANS ratio was 1:30. The spectra were recorded on a Bruker 800 MHz
NMR spectrometer.
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6 M the two populations become nearly equal. These are in
exchange, as could be evidenced by the fact that collection of
one of the fractions, concentrating it and rerunning the FPLC
resulted in the same pattern. This indicates that in this range, the
tetramer dissociates via a dimer. At higher urea concentrations
such as at 9 M, the dimer further dissociates into monomers. Thus
the assembly process would occur as, monomer–dimer–tetramer.
In the 2D 1H–15N HSQC spectra as shown in Fig. 7 under these
conditions there is a gradual change in the number of peaks, the
number decreasing from 6 M urea, where we observe all the
expected peaks, to 4 M urea, at which stage we observe only the
peaks from the C-terminal. At 5 M urea, the peaks from the
segment, M31-L44 are missing which belong to the ﬁrst predicted
helical segment [10] in the protein. This indicates that, in going
from 6 M to 5 M urea an intermediate level exchange is introduced
between dimer and tetramer and this must arise due to local
structure formation in this segment.
3.5. ms-ms time scale dynamics identiﬁes dimer association sites in
the tetramer
Valuable insights into structural transitions during folding/
unfolding of a protein can be derived from studying ms-ms time
scale motions which can be obtained from relaxation dispersion
measurements [15]. We carried out such measurements as
described in Section 2 in the transition zone (4–6 M urea) of
unfolding proﬁle of PfP2 and these are described below. In these
experiments, R2,eff is plotted against the νCPMG and in the presence
of exchange, R2,eff decays with νCPMG and it its absence there will
be no dependence of R2,eff on νCPMG. This provides an unambiguous
method to identify residues undergoing conformational exchange.
Since conformational exchange contribution to R2 depends, among
other things, on the chemical shift frequency separation between
the exchanging sites (i.e. between the two conformations),
exchange seen for a particular residue at one ﬁeld may not be
seen at another, so in order to be more exhaustive we have
recorded these experiments at two ﬁelds. Residue speciﬁc relaxa-
tion dispersion trajectories on backbone 15N spins were recorded
at 500 MHz and 800 MHz (1H frequency) for PfP2 at 5 M and 4 M
urea concentrations. Fig. 8A–C shows plots of R2,eff at 4 M and 5 M
urea condition.
Fig. 6. Urea dependent Gel ﬁltration proﬁles of PfP2: Gel ﬁltration proﬁles of
recombinant PfP2 at 4 M, 5 M and 6 M urea at pH 5.6 with markers BSA and
carbonic anhydrase run on the same column with loading concentrations of
200 mM.
Fig. 7. Urea dependent 1H–15N HSQC spectra of PfP2: Urea concentrations are indicated in the individual panels and the assignments have been marked; pH¼5.6 and
temperature¼251 C.
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Fig. 8. 15N –CPMG relaxation dispersion trajectories for representative residues of PfP2:(A)in 4 M urea recorded at 500 MHz and 800 MHz spectrometer frequencies; (B) in
5 M urea recorded at 500 MHz; (C) in 5 M urea recorded at 800 MHz at pH¼5.6 in all cases.
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From these data, Rex, the conformational exchange contribu-
tions at the two conditions were calculated as described in Section
2 and these results are shown in Fig. 9. It is observed that at 4 M
urea where only the C terminal signals are seen, Rex is almost non-
existent. Interestingly, this is also true for this segment under 5 M
urea condition. However, at 5 M urea, there is a substantial
contribution in the central segment (50–90) and this varies along
the sequence. In Fig. 9 we also show as insets CD spectra at 5 M
and 4 M urea and the observed ellipticities yielded helical contents
of 35% and 40%, respectively, the latter being the helical content
even in the absence of urea; note that this also matches with the
predicted helical structure indicated on the top of the ﬁgure.
Remembering the FPLC results that at 5 M urea there is equili-
brium between dimer and tetramer, we infer that dimer–tetramer
exchange must be contributing to the high Rex seen here and these
regions therefore identify the sites of association of the two dimers
forming the tetramer. We reiterate here that at 5 M urea the peaks
belonging to another segment of the protein, namely, M31-L44,
disappear and this must be attributed to intermediate exchange
time scale folding transitions in that segment inside the dimers
and the tetramers. Similarly, when we go from 5 M to 4 M area the
residues in the central segment which had high Rex values
disappear and this must be attributed again to intermediate
exchange time scale folding transitions in those regions. This is
typical hydrophobic collapse model of protein folding, wherein the
secondary structure forms follows collapse of the chain into a
compact form.
3.6. Structural similarities and dissimilarities between PfP2 and
HuP2
Recently, the structure of human P2 (HuP2) devoid of the C-
terminal 50 residues determined by NMR spectroscopy at pH
7.5 has been published [4]. The structure of heterodimer of human
P1 and P2 full length proteins has also been published [24], and
interestingly, the folded dimer structures are nearly identical in
both. The C-terminal segment is seen to be ﬂexible and the dimers
are formed by packing of four helices (α1–α4) from each of the
monomers. The α1 helices from the two monomers form the core
of the dimer while the other helices (α2, α3, α4) lie on the outer
surface. The packing of the helices is such as to maximize
interactions and we observe that α1 and α4 helices from the two
monomers run in opposite directions. PfP2, unlike human P2,
forms a tetrameric structure at pH 7.4 and is a monomer at pH
2 and in both situations the monomeric units are molten globules;
The 1H-15N HSQC spectrum of PfP2 tetramer shows only 43 peaks
as against all the peaks seen in the case of human P2. The tetramer
is formed by self-association of two dimers as described above. On
the other hand the sequence similarity between HuP2 and PfP2 in
the region (residues 1–75) is 70% and which forms a well folded
stable dimer. Further, the secondary structural elements observed
in HuP2 and the predicted ones in PfP2 are identical; the total
helical content derived from the predicted secondary structure in
PfP2 matches the helical content derived from CD data quite
closely. In PfP2, the predicted helical segments are α1, 33–44; α2,
50–60; α3, 67–78; α4, 82–92. This numbering corresponds to the
recombinant protein used here, which has additional 30 residues
at the N-terminal. Therefore these respective numbers in native
PfP2 would be as listed below and these must be compared with
those in human P2.
PfP2: α1, 3–14; α2, 20–30; α3, 37–48; α4, 52–62
HuP2: α1, 4–14; α2, 20–31; α3, 36–47; α4, 51–59
In HuP2 dimer α1, α10 are in the core of the dimer. This is
indeed the prediction in PfP2 on the basis of R2 data and AABUF
calculations[7, 8] as described previously. Thus we can infer that
the structure of the dimer in the tetramer of PfP2 is very similar to
the dimer structure of HuP2. On this premise we have built a
model for PfP2 tetramer starting from the HuP2 dimer structure
using the contact regions between the two dimers as described
above. This is described below.
3.7. Structural model for PfP2 tetramer
Considering that assembly of the PfP2 tetramer proceeds as
monomer-dimer-tetramer, and noting that the dimer structure of
HuP2 is essentially preserved in the PfP2 tetramer, we begin with
the HuP2 dimer structure. We then generated the dimer of PfP2 by
mutating the residues in HuP2 dimer structure to match the PfP2
sequence using swissPDB viewer [19]. Then the resulting dimer
was energy minimized. This structure is shown in Fig. 10A. We
observe that as a result of mutation some of the residues which
were involved in helix formation in α4 in HuP2 have opened up in
PfP2 dimer. Fig. 10B shows an overlay of HuP2 and PfP2 dimers.
Next, by including constraints of contacts between two PfP2
dimers, derived from Rex data as mentioned in the previous
sections, we docked two units of dimers by using ZDOCK [20].
This is a rigid body modelling algorithm, uses shape complemen-
tarity, desolvation and electrostatic energy contributions between
two protein molecules and searches through the three dimen-
sional space to ﬁnd the most energetically favourable arrangement
using a Fast Fourier Transform (FFT) based scoring procedure. The
resulting structure for the PfP2 tetramer is shown in Fig. 10C. Two
different views are shown to display the interaction sites clearly.
As can be seen the dimeric structures are not perturbed by the
Fig. 9. Plot of Rex vs residue number: The measured values at pH 5.6 and at two
different urea conditions, 5 M and 4 M are shown at 500 and 800 MHz spectro-
meter frequencies. The Rex values for individual residues were determined as
described in the materials and methods. Cylinders on the top show predicted PfP2
helical structures (40%) while inset shows observed CD ellipticity which indicates
increase in helicity from 35% at 5 M urea to 40% on diluting to 4 M urea.
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association process, and the interface is formed by (α3, α4) and
(α30,α40) helices of the two dimers. The α40 helix of one dimer
(green) comes close in contact with the α3 helix (red) of another
dimer (see left panel). Similarly, α30 of one dimer (green) is in close
contact with α4 of another dimer (red) (see right panel). The
helices are closely packed at the interface.
4. Concluding remarks
We have demonstrated that Plasmodium falciparum P2 exists as
a stable tetramer as a basic unit in solution at micromolar
concentration and at pH 7.4. The individual monomers in the
tetramer have molten globule like characteristics. The tetramer
contains hydrophobic pockets contributed by the N terminal
segments of the protein, the C terminal 40 residues remain
unstructured and ﬂexible. From the NMR structure determination
point view there was a great challenge since the native tetramer
displays only 40 peaks which belong to the ﬂexible C-terminal
domain of the protein. Using a strategy of partially unfolding the
tetramer for observing NMR signals from all the residues and
gathering insights into structural and motional transitions, we
have been able to demonstrate that the assembly of the tetramer
occurs as, monomer–dimer–tetramer. Relaxation dispersion mea-
surements at 5 M urea concentration have shown that the central
region (50–90) exhibits high conformational exchange on ms-ms
time scale and these indicated the contact points for association of
two dimers to form the tetramer. From these data we have been
able to build a model for the structure of the tetramer using the
published dimeric structure of HuP2 as the starting point.
It is very interesting to note that PfP2 and HuP2 which have
69% sequence homology in the full length proteins have a basic
difference with regard to the overall behaviours: HuP2 forms a
stable dimer at pH 7.5 while PfP2 forms a molten globule like
tetramer under the same conditions. This may have functional
implications. HuP2 is solely a ribosomal protein where it remains
in an associated state as a dimer in the ribosomal stalk. On the
other hand, PfP2 has both ribosomal and non-ribosomal functions
and the latter seem to involve various types of associated states of
the protein. In the parasite, multiple oligomers are seen during the
nuclear division and the homo-tetramer is translocated to the red
blood cell surface in infected cells. Thus we speculate that the
molten globule like nature of PfP2 structure facilitates structural
rearrangements as required by different kinds of functions.
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Fig. 10. Structure of PfP2:(A) PfP2 dimer obtained from HuP2 structure by mutating the HuP2 sequence with that of PfP2. (B) Overlay of structure of HuP2 homodimer (red)
on PfP2 dimer structure (yellow); (C) Structure of PfP2 tetramer derived using ZDOCK protein docking software. Green and red represents two homodimers of PfP2. Two
views are shown. On the left, helices in green dimer are marked and on the right, helices in the red dimer are marked.
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